Marco Purbhoo

Company: MiNK Therapeutics

Job title: Director, Translational Research

Seminars:

Case Study: Allogeneic Invariant Natural Killer T-Cells: Approaches for Solid Tumor Treatment 11:30 am

Why iNKT cells are a highly effective and efficient platform for allogeneic cell therapy Which approaches does MiNK Therapeutics pursue for the development of solid tumor therapy? Recent MiNK preclinical and clinical data on ongoing programsRead more

day: Conference Day One